DD299062A5 - Verwendung von pteridinen und verfahren zu deren herstellung - Google Patents

Verwendung von pteridinen und verfahren zu deren herstellung Download PDF

Info

Publication number
DD299062A5
DD299062A5 DD89333128A DD33312889A DD299062A5 DD 299062 A5 DD299062 A5 DD 299062A5 DD 89333128 A DD89333128 A DD 89333128A DD 33312889 A DD33312889 A DD 33312889A DD 299062 A5 DD299062 A5 DD 299062A5
Authority
DD
German Democratic Republic
Prior art keywords
group
methyl
morpholino
propyl
pteridine
Prior art date
Application number
DD89333128A
Other languages
German (de)
English (en)
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD299062A5 publication Critical patent/DD299062A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD89333128A 1988-10-01 1989-09-29 Verwendung von pteridinen und verfahren zu deren herstellung DD299062A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD299062A5 true DD299062A5 (de) 1992-03-26

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89333128A DD299062A5 (de) 1988-10-01 1989-09-29 Verwendung von pteridinen und verfahren zu deren herstellung

Country Status (19)

Country Link
EP (1) EP0362645B1 (fr)
JP (1) JPH02256676A (fr)
KR (1) KR910006289A (fr)
AT (1) ATE106728T1 (fr)
AU (1) AU620645B2 (fr)
DD (1) DD299062A5 (fr)
DE (2) DE3833393A1 (fr)
DK (1) DK480489A (fr)
ES (1) ES2056174T3 (fr)
FI (1) FI92699C (fr)
HU (1) HU205761B (fr)
IL (1) IL91814A (fr)
MX (1) MX9203034A (fr)
NO (1) NO175979C (fr)
NZ (1) NZ230833A (fr)
PT (1) PT91836B (fr)
SU (1) SU1720491A3 (fr)
UA (1) UA8028A1 (fr)
ZA (1) ZA897414B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039129A1 (fr) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Effets immunosuppresseurs de derives de la pteridine
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
ATE369861T1 (de) * 2003-09-12 2007-09-15 4 Aza Ip Nv Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
DE602004008312T2 (de) * 2003-10-17 2008-04-17 4 Aza Ip Nv Heterocyclus-substituierte pteridin-derivate und ihre verwendung in der therapie
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
WO2008009078A2 (fr) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Dérivés de la quinazoline tri-substitués en 4,6-dl et en 2,4,6 utilisables pour traiter les infections virales
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
DK3097102T3 (en) 2015-03-04 2018-01-22 Gilead Sciences Inc TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO [3,2-D] PYRIMIDINE COMPOUNDS
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
WO2018045150A1 (fr) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Dérivés de 4,6-diamino-pyrido [3,2-d] pyrimidine en tant que modulateurs du récepteur de type toll
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (fr) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
FI92699C (fi) 1994-12-27
NO175979C (no) 1995-01-11
FI92699B (fi) 1994-09-15
EP0362645A3 (fr) 1992-03-25
EP0362645B1 (fr) 1994-06-08
DE3833393A1 (de) 1990-04-05
EP0362645A2 (fr) 1990-04-11
PT91836B (pt) 1995-07-18
ATE106728T1 (de) 1994-06-15
DK480489D0 (da) 1989-09-29
NZ230833A (en) 1991-05-28
ES2056174T3 (es) 1994-10-01
IL91814A (en) 1994-02-27
ZA897414B (en) 1991-06-26
FI894615A7 (fi) 1990-04-02
DK480489A (da) 1990-04-02
NO893879L (no) 1990-04-02
PT91836A (pt) 1990-04-30
KR910006289A (ko) 1991-04-29
JPH02256676A (ja) 1990-10-17
NO893879D0 (no) 1989-09-29
AU4174989A (en) 1990-04-05
IL91814A0 (en) 1990-06-10
FI894615A0 (fi) 1989-09-29
UA8028A1 (uk) 1995-12-26
SU1720491A3 (ru) 1992-03-15
HUT52504A (en) 1990-07-28
MX9203034A (es) 1992-07-01
DE58907824D1 (de) 1994-07-14
HU205761B (en) 1992-06-29
AU620645B2 (en) 1992-02-20
NO175979B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
EP1599478B1 (fr) Dihydropteridinones, prodede de production et utilisation de ces dernieres comme medicaments
DE69202243T2 (de) 2,4-Diaminochinazolin-Derivate, um die Antitumorwirkung zu erhöhen.
DE69229834T2 (de) Piperazinderivate als 5-ht rezeptor antagonisten
DE69613240T2 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
EP0362645B1 (fr) Utilisation de ptéridines pour la prévention de la résistance primaire et secondaire pendant la chimiothérapie et les mécaments contenant ces substances
JPS5865267A (ja) スルホンアミド誘導体、その製法及びそれを含む医薬組成物
CH616677A5 (fr)
DE60302221T2 (de) Heteroaryl substituierte 2-pyridinyl und 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-onderivate
EP1632493A1 (fr) Dérivés de dihydropteridine, méthodes de préparation et utilisation en tant que médicament
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
DE69533194T2 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
DD295088A5 (de) Verwendung von aryl-substituierten aminderivaten zur herstellung von arzneimitteln und verfahren zu ihrer herstellung
US5932593A (en) Piperidine derivatives and anti-platelet agents containing the same
DE10202468A1 (de) Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE19636769A1 (de) 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE2502397A1 (de) Guanidinderivate, ein verfahren zu deren herstellung sowie arzneimittel
DE3788195T2 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
DE69612753T2 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
EP0645390A1 (fr) Pyrimido 5,4-d pyrimidines trisubstitués pour moduler la résistance multidrogue, médicaments les contenant et procédés pour leur préparation
DE60104130T2 (de) 1-(alkyl), 1-[(heteroaryl)alkyl] und 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-onderivate
CH643549A5 (de) N-(trimethoxybenzyl)-n'-phenylpiperazine.
DE60205397T2 (de) 4-(thio- oder selenoxanthen-9-yliden)-piperidin oder acridin derivate und ihre verwendung als selektive 5ht2b rezeptorantagonisten
DE4009941A1 (de) Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel
DE2753791C2 (fr)
EP0589908B1 (fr) Thiazolin-2-ones a substitution aminoalkyle, leur preparation et leur utilisation

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee